| Size | Price | Stock |
|---|---|---|
| 100 mg | Get quote | |
| 250 mg | Get quote | |
| 500 mg | Get quote | |
| We match the lowest price on market. | ||
We offer a substantial discount on larger orders, please inquire via [email protected]
or Fax: (86)21-58955996
Inquiry for price and availability only. Please place your order via our email or fax.
| Cat. No. : | HY-12924 |
| M.Wt: | 349.40 |
| Formula: | C18H19N7O |
| Purity: | >98 % |
| Solubility: |
ATR-IN-1 is a selective ATR inhibitor with an IC50 of 0.5 nM. ATR-IN-1 inhibits the growth of ATM-deficient melanoma. ATR-IN-1 shows no hERG inhibitory effect. ATR-IN-1 can be used for research on melanoma[1].
In Vitro:ATR-IN-1 (Compound 13) inhibits ATR with an IC50 of 0.0005 µM and shows selectivity over ATM (IC50 15 µM) and DNAPK (IC50 >25 µM)[1].
ATR-IN-1 (1 h) does not inhibit mTOR signaling in TSC1−/− MEF cells (IC50 >13 µM)[1].
ATR-IN-1 has a hERG IC50 >30 µM by automated whole-cell electrophysiology[1].
ATR-IN-1 does not inhibit CYP3A4, 2D6, 2C9, or 1A2 (IC50 >24 µM)[1].
ATR-IN-1 (72 h) inhibits the growth of ATM-null HT144 melanoma cells with a GI50 of 0.35 µM after 72 h continuous exposure[1].
Lorem ipsum dolor sit amet, consectetur adipisicing elit. Autem earum hic iste maiores, nam neque rem suscipit. Adipisci consequatur error exercitationem fugit ipsam optio qui, quibusdam repellendus sed vero! Debitis.
Inquiry Information
Your information is safe with us.